Literature DB >> 7970457

Incidence of bacteremia associated with chorionic villus sampling.

N S Silverman1, M W Sullivan, D L Jungkind, V Weinblatt, K Beavis, R J Wapner.   

Abstract

OBJECTIVE: To assess the frequency of transient bacteremia among women undergoing transabdominal and transcervical chorionic villus sampling (CVS).
METHODS: One hundred fourteen women undergoing CVS consented to participate in a university review board-approved study protocol. Exclusion criteria included known cardiac valve anomaly or replacement (or other prosthetic) and antibiotic use within the preceding 21 days. Blood cultures (aerobic and anaerobic) were drawn by a single operator on all patients, before CVS and within 15 minutes after completing CVS. Either the catheter tip or needle tip aspirate from each procedure was also sent for culture.
RESULTS: Post-procedure bacteremia was detected in two (1.8%) of the patients undergoing CVS. These two patients both had their procedures performed transcervically, resulting in a 4.1% (two of 49) bacteremia rate after transcervical CVS, compared to none (zero of 65) in the transabdominal group (P = .36). The incidence of positive cultures from sampling instruments was also higher in the transcervical group (16.3 versus 0%; P = .003), but did not result in comparable rates of bacteremia among patients with positive instrument cultures.
CONCLUSIONS: In this study, CVS was associated with a low rate of bacteremia, regardless of the procedure route. Recommendations for antibiotic prophylaxis in women with abnormal cardiac valves should parallel those for spontaneous vaginal delivery and other comparable genitourinary procedures.

Entities:  

Mesh:

Year:  1994        PMID: 7970457

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  First report of Atopobium vaginae bacteremia with fetal loss after chorionic villus sampling.

Authors:  Marjolein Knoester; Lisa E E L O Lashley; Els Wessels; Dick Oepkes; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Development of a mouse model of ascending infection and preterm birth.

Authors:  Nicholas R Spencer; Enkhtuya Radnaa; Tuvshintugs Baljinnyam; Talar Kechichian; Ourlad Alzeus G Tantengco; Elizabeth Bonney; Ananth Kumar Kammala; Samantha Sheller-Miller; Ramkumar Menon
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.